Healthier Capital

Qualified Health is a technology company specializing in generative artificial intelligence (AI) for the healthcare industry. It offers an infrastructure solution that ensures the safe and effective use of AI in medicine. This includes continuous algorithm performance monitoring, active AI governance, and the development of AI agents tailored to healthcare needs. The company partners with leading health systems to revolutionize healthcare in the United States.

Hyro develops a conversational artificial intelligence platform that enhances user interactions across various digital channels. By leveraging natural language understanding, the platform allows organizations to create plug-and-play AI assistants capable of engaging customers through voice and chat. Hyro's innovative approach enables seamless ingestion of existing data to automatically build knowledge graphs, facilitating frictionless deployment and maintenance without the need for integration, playbooks, or extensive training data. The platform also features an advanced analytics dashboard, allowing organizations to customize conversations and improve customer engagement effectively.

Medeloop accelerates medical discoveries by providing a platform that seamlessly links, harmonizes, and analyzes vast amounts of health data. It pioneers AI techniques to find biomarkers for clinical researchers, shortening the research process and enabling more publications.

Amae Health is a clinic specializing in mental wellness care for individuals with severe mental illnesses. It offers tailored treatments across behavioral medicine, primary care, and social health services, aiming to stabilize patients, enhance their well-being, and prevent future crises. The company's integrated care platform is designed to address the unique needs of its patients, enabling improved health outcomes.

Ezra AI, Inc. is a company focused on developing artificial intelligence technology to enhance cancer detection through investigational devices. Established in 2017 and headquartered in New York, it has pioneered a novel approach to cancer screening utilizing full-body MRI technology supported by AI. The company's initial product is an FDA-cleared software designed to assist radiologists in interpreting MRI images specifically for prostate cancer. Ezra AI primarily serves customers in New York and California, aiming to improve early cancer detection and diagnosis through its innovative solutions.